+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
From
From
Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • April 2025
  • 1432 Pages
  • Global
From
Skin Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Skin Cancer Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 483 Pages
  • Global
From
Ophthalmic Medical Lasers Market Report 2025 - Product Thumbnail Image

Ophthalmic Medical Lasers Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
From
Biologics Market Report 2025-2035 - Product Thumbnail Image

Biologics Market Report 2025-2035

  • Report
  • March 2025
  • 367 Pages
  • Global
From
Nivolumab Market Report 2025 - Product Thumbnail Image

Nivolumab Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Diabetic Macular Edema - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Diabetic Macular Edema - Global Clinical Trials Review, 2025

  • Clinical Trials
  • February 2025
  • 604 Pages
  • Global
From
From
Loading Indicator